5月23日,“药王”恒瑞医药在港交所正式挂牌上市,成功实现“A+H”两地上市。此次恒瑞医药全球发售约2.3亿股,发行定价为44.05港元/股,该发行价格为预计发行价格的上限。 恒瑞医药H股首日上市交易,开盘上涨29.40%,开盘价为57.00港元/股。截至上午收盘,上涨30.65%。 《每日经济新闻》记者在恒瑞医药港股上市现场看到,恒瑞医药管理层齐聚一堂,公司董事长孙飘扬参加了上市敲锣环节,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.